Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.
Times cited: 247
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.
Journal of Clinical Oncology.
Times cited: 39